Activated Charcoal (AC): To give or not to give?
By Dr. Ferrari
(Reviewed by deSouza)
History of Activated Charcoal
- 1831 French Academy of Medicine: Tovery takes AC with a lethal dose of strychnine without symptoms
-
1960s, review article in Journal of Pediatrics, popularizes its use
- Standard at this time was gastric decontamination followed by AC
- Standard at this time was gastric decontamination followed by AC
What is Activated Charcoal?
- Synthesis: Pulverized carbonaceous materials (sawdust, peat or coconut shells) is heated to 600-900°C
-
Activation: Steam or hot air erodes the surface thereby increasing surface area
– Net Surface Area: 800-1200m2/g (normal), 2800-3500 m2/g (superactivated)
Mechanism
-
Absorption
- Weak intermolecular bonds (Van der Waals)
- Organic, large, poorly water soluble
- Correlates with volume of distribution
- Weak intermolecular bonds (Van der Waals)
-
Disruption of enterohepatic circulation
- Toxins are conjugated in liver by glucuronides
- Dumped back into intestine
- Hydrolysis by beta-glucuronidase frees toxin to be reabsorbed
- Charcoal can bind before reabsorption
- Toxins are conjugated in liver by glucuronides
-
Back Diffusion – “Gastrointestinal Dialysis”
- Drug diffuses from circulation back into intestinal tract
- Studies of IV drug administration treated with AC show reduction in T1/2 (theophylline and digoxin)
- Drug diffuses from circulation back into intestinal tract
Nuts & Bolts
-
Dose: AC grams:drug grams or 1g/kg
10:1
40:1
-
Contraindications
- Caustic/volatile substances
-
Active vomiting
- Consider antiemetics
- Consider antiemetics
-
Can’t protect airway
- Able to protect airway – drink it
- Unable to protect airway – Intubate and provide by NG tube
- Able to protect airway – drink it
- Known not to bind: iron, lithium, potassium, ethanol
- Caustic/volatile substances
Complications
- Vomiting
- Aspiration pneumonitis
- Constipation or diarrhea (with cathartics)
- Cases: appendicitis, perforation
Guidelines
- “In the absence of satisfactorily designed clinical studies demonstrating benefit from its use, the administration of activated charcoal may be considered if a patient has ingested a potentially toxic amount of a poison up to one hour following ingestion. The potential for benefit after one hour cannot be excluded.”
Position Paper: Single-Dose Activated Charcoal
American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists
- “50g AC to cooperative, awake adult within 2 hours of ingestion of toxic dose of intermediate-release acetaminophen and 4 hours of modified-release acetaminophen…For doses of greater than 30g, AC up to 4hrs…For massive modified-release acetaminophen, absorption may continue for 24hrs and patients may still benefit from activated charcoal after 4hrs”
Summary Statement: new guidelines for the management of paracetamol poisoning in Australia and New Zealand
Debate
-
Does it work?
-
Many studies show reduction in toxin concentration
- Varying levels of quality of evidence
- Varying levels of quality of evidence
- No study shows improvement in morbidity, mortality, ICU or hospital length of stay
-
-
Why 1hr?
-
Multiple studies show decreased efficacy after 1hr
- Riddled with mixed data due to concurrent gastric lavage/ use of ipecac
- Riddled with mixed data due to concurrent gastric lavage/ use of ipecac
- Multiple studies show good efficacy at 2hrs
- Some studies show efficacy at 4hrs
- Minimal convincing data after 4hrs
-
Prolonged Gastric Emptying Half-Time and Gastric Hypomotility After Drug Overdose (Adams, AJEM 2003)
- TCA, acetaminophen, opiod-acetaminophen, carbamazepine, phenytoin
- Gastric scintigraphy after overdose compared to scintigraphy after recovery (control)
- Mean age: 29 years, 75% Female, 25% Male
- Median: 94 min with overdose, 36 min control
- TCA, acetaminophen, opiod-acetaminophen, carbamazepine, phenytoin
-
Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal (Roberts, Therapeutic Drug Monitoring, 2006)
-
Terminal half-life of yellow oleander decreased by 50% in those who received AC
- Mean 33.9hrs v 62.9hrs
- Mean 33.9hrs v 62.9hrs
-
-
Bottom line
- Always consider it
- There is a risk/Benefit balance
- On the In-Service exam: give within 1hr of ingestion for appropriate substances in individuals who can protect their airway
Edited by Dr. deSouza
References:
Adams BK, Mann MD, Aboo A, Isaacs S, Evans A. Prolonged gastric emptying half-time and gastric hypomotility after drug overdose. Am J Emerg Med. 2004 Nov;22(7):548-54. PubMed PMID: 15666259.
Derlet RW, Albertson TE. Activated charcoal–past, present and future. West J Med. 1986 Oct;145(4):493-6. Review. PubMed PMID: 3538661; PubMed Central PMCID: PMC1306980.
Olson KR. Activated charcoal for acute poisoning: one toxicologist’s journey. J Med Toxicol. 2010 Jun;6(2):190-8. doi: 10.1007/s13181-010-0046-1. Review. PubMed PMID: 20490748; PubMed Central PMCID: PMC2919687.
Roberts DM, Southcott E, Potter JM, Roberts MS, Eddleston M, Buckley NA. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated
charcoal. Ther Drug Monit. 2006 Dec;28(6):784-92. PubMed PMID: 17164695; PubMed Central PMCID: PMC2296884.
Yeates PJ, Thomas SH. Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose. Br J Clin Pharmacol. 2000 Jan;49(1):11-4. PubMed PMID: 10606832; PubMed Central PMCID: PMC2014891.
Position Paper: Single-Dose Activated Charcoal, American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists, (https://www.clintox.org/documents/positionpapers/SingleDoseActivatedCharcoal.pdf), 2005
Summary Statement: new guidelines for the management of paracetamol poisoning in Australia and New Zealand, (www.mja.com.au/sites/default/files/issues/203_05/Guidelines_paracetamol_Aus_NZ_2015.pdf), 2015
Brian
Latest posts by Brian (see all)
- Patellar Dislocation and Reduction - January 10, 2017
- ED Management of Hypercalcemia of Malignancy - November 12, 2016
- Disseminated Gonorrhea - August 17, 2016
0 Comments